To further demonstrate a potential global role of EXT1 in cancer, we took advantage of the SL (24) and the SDL (25) principles, whereby, for each pair, individual gene inactivation (SL) or expression variation (SDL) result in viable phenotypes, whereas combined perturbations are lethal. This evidence concerns the gene EXT1 and cancer.